Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prothena Corporation plc PRTA

Healthcare Biotechnology
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the... see more

Recent & Breaking News (NDAQ:PRTA)

Prothena to Report First Quarter 2020 Financial Results on May 6

Thomson Reuters ONE April 29, 2020

Prothena Provides Additional Information Regarding Upcoming Annual General Meeting of Shareholders in Response to COVID-19

GlobeNewswire April 24, 2020

Update on Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinson's Disease

GlobeNewswire April 22, 2020

Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 3, 2020

Baseline Data from Phase 2 PASADENA Study of Prasinezumab (PRX002/RG7935) in Parkinson's Disease to be Presented at AAT-AD/PD

GlobeNewswire March 31, 2020

Prothena Announces Appointment of Brandon Smith as Chief Business Officer

GlobeNewswire March 3, 2020

Prothena Reports Fourth Quarter and Full Year 2019 Financial Results, and Provides Financial Guidance and R&D Update

GlobeNewswire February 12, 2020

Prothena to Report Fourth Quarter and Full Year 2019 Financial Results and Host Webcast Conference Call on February 12

GlobeNewswire February 5, 2020

Prothena Announces Appointment of Oleg Nodelman to its Board of Directors

Thomson Reuters ONE December 5, 2019

Prothena Announces Appointment of Oleg Nodelman to its Board of Directors

GlobeNewswire December 5, 2019

Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update

GlobeNewswire November 5, 2019

Prothena to Report Third Quarter 2019 Financial Results on November 5

GlobeNewswire October 29, 2019

Labaton Sucharow LLP and Levi & Korsinsky LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Ordinary Shares of Prothena Corporation plc in In re Prothena Corporation plc Securities Litigation, No. 1:18-cv-06425-ALC

PR Newswire October 7, 2019

Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update

GlobeNewswire August 6, 2019

Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update

Thomson Reuters ONE August 6, 2019

Prothena to Report Second Quarter 2019 Financial Results on August 6

Thomson Reuters ONE July 30, 2019

Prothena Announces Appointment of Paula K. Cobb to its Board of Directors

Thomson Reuters ONE July 1, 2019

Prothena Announces Appointment of Paula K. Cobb to its Board of Directors

GlobeNewswire July 1, 2019

Prothena to Participate in the Jefferies Healthcare Conference

Thomson Reuters ONE May 30, 2019

Prothena to Participate in the Jefferies Healthcare Conference

GlobeNewswire May 30, 2019